Skip to main content
. 2021 Mar 4;12:1434. doi: 10.1038/s41467-021-21576-8

Fig. 1. Temporal and multi-regional spatial sampling reveals limited acquisition of point mutations during melanoma progression to end-stage disease.

Fig. 1

A Spatial distribution of pre-mortem and autopsy samples for CASCADE patient CAS-D. Created with BioRender.com. B Unique SNVs and small indels detected across tumours from each patient. The identifier for each sample is described in Tables S1 and S2. Y-axis indicates the number of mutations in each patient. C Mutational load of SNVs and small indels across tumours from each patient. Y-axis is shown in a logarithmic scale.